Lupin launches generic contraceptive drug in US

Logo Indiatimes
Indiatimes
By Pti

Drug maker Lupin On Thursday said it has launched Merzee capsules, a medication used to prevent pregnancy, in the US market. The Mumbai-based drug maker has launched the product in the US market under exclusive license, marketing and distribution agreement with Slayback Pharma LLC, Lupin Ltd said in a statement.

Slayback had earlier launched this product in the US in February 2021.

Merzee (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1 mg/20 mcg is a generic equivalent of Allergan Pharmaceuticals' Taytulla capsules.

As per IQVIA MAT February 2022 data, Norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules, 1 mg/20 mcg had estimated annual sales of USD 90 million in the US.

Continue read on indiatimes.com

Logo Business Standard
Lupin rose 1.65% to Rs 785.70 after the global pharma major announced that the company is launching Merzee capsules, 1 mg/ 20 mcg, in the U.S. market, under...

Logo Business Standard
Drug maker Lupin On Thursday said it has launched Merzee capsules, a medication used to prevent pregnancy, in the US market. The Mumbai-based drug maker has...

Logo Business Standard
Lupin said that it has received approval from the United States Food and Drug Administration (FDA) for Vigabatrin for oral solution USP. The approved...

Logo Indiatimes
Pharma major Dr Reddy's Laboratories Ltd on Tuesday said it has launched its generic Methylprednisolone Sodium Succinate for injection, indicated for various...

Logo Business Standard
Lupin today announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application...

Logo Indiatimes
Alembic Pharmaceuticals Ltd on Thursday said it has received tentative approval from the US health regulator for its generic version of Dabigatran Etexilate...

Logo Benzinga
Dr. Reddy's Laboratories Ltd. ((BSE: 500124,DRREDDYRDYDRREDDY along with its subsidiaries together referred to as Dr. Reddy's)) today announced the launch of...

Logo Business Standard
Drug maker Lupin on Tuesday said it has inked a licensing pact with Alvion Pharmaceuticals to commercialise medicines for cardiometabolic diseases in...

Logo Indiatimes
NEW DELHI: Shares of Lupin gained nearly 4 per cent on Thursday as it received approval from the United States Food and Drug Administration (FDA) for its...

Logo Nasdaq
MarketsBy Rtt News16 Mar
(RTTNews) - The U.S. Food and Drug Administration approved Mylan Pharmaceuticals, Inc.'s generic of Symbicort (budesonide and formoterol fumarate dihydrate)...

Logo Business Standard
Pharmaceuticals firm Indoco Remedies Ltd on Tuesday said it has received final approval from the US health regulator for its generic Lacosamide tablet...

Logo Business Standard
Strides Pharma Science on Monday said it has inked a sub-license agreement with Medicines Patent Pool to commercialise a generic version of Pfizer's COVID-19...

Logo Indiatimes
Drug maker Lupin on Thursday said it has completed the acquisition of a portfolio of brands from Anglo-French Drugs & Industries Limited (AFDIL) and its...

Logo Business Standard
Lupin rose 1.42% to Rs 783.95 after the company announced the completion of acquisition of a portfolio of brands from Anglo-French Drugs & Industries...

Logo Benzinga
[TODAY ONLY] For only $7, get 2 bear market beating options trade straight to your inbox and SMS every month! Click Here Now to Get Started! Approval...

Logo Business Standard
Strides Pharma Science jumped 4.33% to Rs 348.55 after the company announced d a sub-license agreement with Medicines Patent Pool (MPP) to commercialize a...

Logo Business Standard
Alembic Pharmaceuticals announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug...

Logo Indiatimes
Torrent Pharma and Aurobindo Pharma on Thursday said it has signed a non-exclusive license agreement with Medicine Patent Pool (MPP) for manufacture and...

Logo Business Standard
The pharma major after market hours on Thursday announced that its wholly owned subsidiary Novel Laboratories based in Somerset, New Jersey (USA) received...

Logo Business Standard
Unichem Laboratories advanced 2.46% to Rs 251.50 after it has received ANDA approval for its Nebivolol tablets (2.5 mg, 5 mg, 10 mg, 20 mg) from the drug...